beta-alanine has been researched along with quinazolines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furberg, CD; Moore, TJ | 1 |
| Brodsky, SV; Hebert, LA; Ivanov, I; Muni, N; Nadasdy, G; Nadasdy, T; Rovin, BH; Satoskar, AA; Vance, JC; Ware, KM | 1 |
| Hong, SE; Jang, YS; Jeong, W; Jo, YJ; Kim, H; Kim, J; Lee, GR; Lee, HI; Lee, HJ; Lee, J; Lee, JS; Oh, SH | 1 |
3 other study(ies) available for beta-alanine and quinazolines
| Article | Year |
|---|---|
The safety risks of innovation: the FDA's Expedited Drug Development Pathway.
Topics: Anticoagulants; Antineoplastic Agents; Benzimidazoles; beta-Alanine; Carcinoma, Neuroendocrine; Clinical Trials as Topic; Dabigatran; Drug Approval; Efficiency, Organizational; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Multiple Sclerosis; Patient Safety; Piperidines; Propylene Glycols; Quinazolines; Risk; Sphingosine; Stroke; Thyroid Neoplasms; Time Factors; United States; United States Food and Drug Administration | 2012 |
Oral warfarin and the thrombin inhibitor dabigatran increase blood pressure in rats: hidden danger of anticoagulants?
Topics: Acetylcysteine; Animals; Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzimidazoles; beta-Alanine; Blood Pressure; Dabigatran; Disease Models, Animal; Dose-Response Relationship, Drug; Free Radical Scavengers; Nephrectomy; Pyrroles; Quinazolines; Rats; Receptor, PAR-1; Renal Insufficiency, Chronic; Vitamin K; Warfarin | 2015 |
Effective killing of cancer cells and regression of tumor growth by K27 targeting sulfiredoxin.
Topics: A549 Cells; Acetylcysteine; Adenocarcinoma, Bronchiolo-Alveolar; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; beta-Alanine; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Epithelial Cells; Female; Gene Expression; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mitochondria; Molecular Targeted Therapy; Oxidative Stress; Oxidoreductases Acting on Sulfur Group Donors; Quinazolines; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2016 |